0001818644 false 0001818644 2022-08-15 2022-08-15 0001818644 LIDR:CommonStockParValue0.0001PerShareMember 2022-08-15 2022-08-15 0001818644 LIDR:WarrantsToReceiveOneShareOfCommonStockMember 2022-08-15 2022-08-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 15, 2022

 

AEYE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-39699   37-1827430
(State or other jurisdiction   (Commission File Number)   (IRS Employer Identification No.)
of incorporation)        

 

One Park Place, Suite 200, Dublin, California   94568
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (925) 400-4366

 

 
(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

¨       Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨       Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

¨       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨       Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.0001 per share LIDR The Nasdaq Stock Market LLC
Warrants to receive one share of Common Stock LIDRW The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 
   

 

Item 2.02Results of Operations and Financial Condition.

 

On August 15, 2022, AEye, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2022. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information provided in Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Item 9.01. Financial Statement and Exhibits.
       
  (d) Exhibits.
       
  Exhibit Number Description
       
  99.1   Press release dated August 15, 2022.
       
  104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

 

 

 

 

 

 

 

   

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    AEye, Inc.
     
Dated: August 15, 2022    
    By: /s/ Robert A. Brown
      Robert A. Brown
      Chief Financial Officer

 

 

 

 

 

 

 

 

 

   

 

FOR IMMEDIATE RELEASE

 

AEYE REPORTS SECOND QUARTER 2022 RESULTS

 

Company exceeded its financial expectations for the second quarter

Entrance into new markets and continued momentum with customers provide foundation for sustainable growth

 

Dublin, CA – August 15, 2022 — AEye, Inc. (Nasdaq: LIDR), a global leader in adaptive, high-performance lidar solutions, today announced its results for the second quarter ended June 30, 2022.

 

Blair LaCorte, Chief Executive Officer of AEye, said, “We achieved significant progress strengthening our platform to drive long-term growth and are pleased with our performance during the second quarter. Our industry leading technology, talented team, and strong reputation continue to position us as a leader in the lidar market. This momentum is reflected in the progress we are making in the auto market, as well as new market segments including our recent partnership with Booz Allen to support productization for defense applications.”

 

“While supply chain disruption and inflationary challenges continue to impact the industry and broader economy, we are confident that our innovative, capital-light, and high margin business model will enable us to achieve future growth. We remain encouraged with the traction we have gained, and are excited for what has yet to come,” concluded LaCorte.

 

Q2 2022 Financials

 

Revenue of $0.7 million in the second quarter of 2022.

 

GAAP net loss was $(26.5) million in the second quarter of 2022, or $(0.17) per share based on 157.3 million weighted average shares outstanding.

 

Non-GAAP net loss was $(19.8) million in the second quarter of 2022, or $(0.13) per share based on 157.3 million weighted average shares outstanding.

 

Cash, cash equivalents, and marketable securities were $125.8 million as of June 30, 2022. This excludes up to $123.6 million in available liquidity from our Common Stock Purchase Agreement.

 

Conference Call and Webcast Details

 

AEye management will hold a conference call today, August 15, 2022, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these results. AEye CEO Blair LaCorte and CFO Bob Brown will host the call, followed by a question-and-answer session.

 

The webcast and accompanying slides will be accessible via the company’s website at https://investors.aeye.ai/.

 

The call is also accessible via telephone through the following details:

 

   

 

 

Dial in Information:

 

Participant Toll-Free Dial-In Number: 844-763-8274
Participant International Dial-In Number: 412-717-9224

 

About AEye

AEye’s unique software-defined lidar solution enables advanced driver-assistance, vehicle autonomy, smart infrastructure, logistics, and off-highway applications that save lives and propel the future of transportation and mobility. AEye’s 4Sight™ Intelligent Sensing Platform, with its adaptive sensor-based operating system, focuses on what matters most; delivering faster, more accurate, and reliable information. AEye’s 4Sight™ products, built on this platform, are ideal for dynamic applications which require precise measurement imaging to ensure safety and performance. AEye has a global presence through its offices in Germany, Japan, Korea, and the United States.

 

Non-GAAP Financial Measures

The non-GAAP measures provided in this press release should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with generally accepted accounting principles (GAAP) in the United States. A reconciliation between GAAP and non-GAAP financial data is included in the supplemental financial data attached to this press release. Non-GAAP financial measures do not have any standardized meaning and are therefore unlikely to be comparable to similarly titled measures presented by other companies. AEye considers these non-GAAP financial measures to be important because they provide additional insight into the Company’s on-going performance. The Company provides this information to investors for a more consistent basis of comparison and to help investors evaluate the results of the Company’s on-going operations, and to help enable more meaningful period-to-period comparison. Non-GAAP financial measures are presented only as supplemental information for the purpose of understanding the Company’s operating results. The non-GAAP financial measures should not be considered a substitute for financial information presented in accordance with GAAP.

 

This presentation includes non-GAAP financial measures, including:

 

Non-GAAP net loss which is defined as GAAP net loss plus stock-based compensation, plus expenses related to filing Registration Statements on Form S-1, plus stock issuance costs, plus change in fair value of embedded derivative and warrant liabilities, less the gain on PPP loan forgiveness; and

 

Adjusted EBITDA which is defined as non-GAAP net loss plus amortization and depreciation expense, plus interest expense and other, less interest income and other, plus provision for income tax expense.

 

Forward-Looking Statements

Certain statements included in this press release that are not historical facts are forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are sometimes accompanied by words such as “believe,” “continue,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “predict,” “plan,” “may,” “should,” “will,” “would,” “potential,” “seem,” “seek,” “outlook,” and similar expressions that predict or indicate future events or trends, or that are not statements of historical matters.

 

   

 

 

Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward looking statements included in this press release include statements about AEye’s products, the Company’s progress in commercialization, the potential of new market segments, and expected future results, among others. These statements are based on various assumptions, whether or not identified in this press release. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are very difficult or impossible to predict and will differ from the assumptions. Many actual events and circumstances are beyond the control of AEye. Many factors could cause actual future events to differ from the forward-looking statements in this press release, including but not limited to: (i) the risks that AEye’s entrance into new markets or continued end-market momentum will provide a foundation for sustainable growth to the extent anticipated or in the timeframe contemplated, or at all; (ii) the risks that the significant progress strengthening AEye’s platform to drive long-term growth will continue to the extent anticipated or in the timeframe contemplated, or at all; (iii) the risks that AEye’s technology will not lead the industry in the short or long term, or both, due to competition, internal challenges, or both, such that AEye is unable to establish or maintain a position as a leader in the lidar market; (iv) the risks that AEye may not be able to successfully navigate either or both of the supply chain disruptions it faces or the inflationary challenges that currently exist and which may continue for a time period that is longer than anticipated, or is more severe than contemplated; (v) the risks that AEye’s innovative, capital-light, and high margin business model will not enable AEye to achieve future growth to the extent anticipated or in the timeframe contemplated, or at all; (vi) the risks that the traction gained by AEye to date will translate into future growth, revenue, or profitability to the extent anticipated or in the timeframe contemplated, or at all; (vii) the risks that AEye will be unable to strengthen its competitive position or deliver on its key objectives in 2022 due to supply chain disruptions, economic uncertainties, or otherwise; (viii) the risks that competing technologies will improve overtime to become operationally equivalent or more cost-effective, or both, as compared to AEye’s product offering; (ix) the risks that competitors may introduce products with similar capabilities to AEye’s products and such competitive products are able to take some or all of the market share away from AEye; (x) the risks that AEye’s products will not meet the diverse range of performance and functional requirements of AEye’s target markets and customers; (xi) the risks that AEye’s products will not function as anticipated by AEye or by AEye’s target markets and customers; (xii) the risks that the size of the total available market for the use of lidar will be smaller than predicted or take longer to come to fruition than predicted; (xiii) the risk that laws and regulations are adopted impacting the use of lidar that AEye is unable to comply with, in whole or in part; (xiv) changes in competitive and regulated industries in which AEye operates, variations in operating performance across competitors, and changes in laws and regulations affecting AEye’s business; (xv) the risks that AEye is unable to adequately implement its business plans, forecasts, and other expectations, and identify and realize additional opportunities; and (xvi) the risks of downturns and a changing regulatory landscape in the highly competitive and evolving industry in which AEye operates. These risks and uncertainties may be amplified by the COVID-19 pandemic, including the Delta and Omicron variants, as well as future variants and subvariants, which has caused significant economic uncertainty. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the Quarterly Report on Form 10-Q that AEye has most recently filed with the U.S. Securities and Exchange Commission, or the SEC, and other documents filed by us or that will be filed by us from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made.

 

Readers are cautioned not to put undue reliance on forward-looking statements; AEye assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. AEye gives no assurance that AEye will achieve any of its expectations.

 

 

   

 

 

AEYE, INC.
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)
      
   June 30, 2022  December 31, 2021
       
ASSETS          
Current Assets:          
Cash and cash equivalents  $4,236   $14,183 
Marketable securities   121,526    149,824 
Accounts receivable, net   189    4,222 
Inventories, net   5,066    4,085 
Prepaid and other current assets   4,151    5,051 
Total current assets   135,168    177,365 
Right-of-use assets   16,186    —   
Property and equipment, net   6,717    5,129 
Restricted cash   2,150    2,150 
Other noncurrent assets   1,098    1,509 
Total assets  $161,319   $186,153 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)          
Current Liabilities:          
Accounts payable   3,836    2,542 
Accrued expenses and other current liabilities   10,792    8,739 
Contract liabilities   1,633    2,287 
Total current liabilities   16,261    13,568 
Operating lease liabilities, noncurrent   17,424    —   
Deferred rent, noncurrent   —      3,032 
Other noncurrent liabilities   46    786 
Total liabilities   33,731    17,386 
Stockholders’ Equity (Deficit):          
Preferred stock   —      —   
Common stock   16    16 
Additional paid-in capital   332,344    320,937 
Accumulated other comprehensive loss   (1,629)   (391)
Accumulated deficit   (203,143)   (151,795)
Total stockholders’ equity (deficit)   127,588    168,767 
Total liabilities and stockholders’ equity (deficit)  $161,319   $186,153 

 

 

   

 

 

AEYE, INC.
Condensed Consolidated Statements of Operations
(In thousands, except share and per share data)
(Unaudited)
   Three months ended June 30,  Six months ended June 30,
   2022  2021  2022  2021
             
Revenue:                    
Prototype sales  $195   $228   $530   $461 
Development contracts   511    519    1,258    615 
Total revenues   706    747    1,788    1,076 
Cost of revenue   1,427    454    2,909    1,071 
Gross profit (loss)   (721)   293    (1,121)   5 
                     
Operating Expenses:                    
Research and development   10,762    5,726    19,338    11,562 
Sales and marketing   5,323    1,911    9,939    3,498 
General and administrative   9,827    4,750    21,157    7,760 
Total operating expenses   25,912    12,387    50,434    22,820 
Loss from operations   (26,633)   (12,094)   (51,555)   (22,815)
                     
Other income (expense), net:                    
Change in fair value of embedded derivative liability and warrant liabilities   141    (16)   109    (119)
Gain on PPP loan forgiveness   —      2,297    —      2,297 
Interest income and other   350    2    774    5 
Interest expense and other   (307)   (1,264)   (650)   (1,952)
Total other income (expense), net   184    1,019    233    231 
Provision for income tax expense   18    —      26    —   
Net loss  $(26,467)  $(11,075)  $(51,348)  $(22,584)
                     
Per Share Data                    
Net loss per common share (basic and diluted)  $(0.17)  $(0.11)  $(0.33)  $(0.22)
Weighted average common shares outstanding (basic and diluted)   157,310,419    101,458,886    156,071,676    101,398,851 

 

 

 

   

 

 

AEYE, INC.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
   
   Six  Months Ended June 30,
   2022  2021
       
Cash flows from operating activities:          
Net loss  $(51,348)  $(22,584)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   463    498 
Noncash lease expense relating to operating lease right-of-use assets   654    —   
Inventory write-downs, net of scrapped inventory   335    —   
Change in fair value of embedded derivative liability and warrant liabilities   (109)   119 
Noncash gain on PPP loan forgiveness   —      (2,297)
Stock-based compensation   11,897    4,230 
Amortization of debt issuance costs   —      437 
Amortization of debt discount   —      543 
Amortization of premiums on marketable securities, net of change in accrued interest   826    —   
Other   —      189 
Changes in operating assets and liabilities:          
Accounts receivable, net   4,033    18 
Inventories, net   (1,316)   (1,813)
Prepaid and other current assets   900    (316)
Other noncurrent assets   411    (144)
Accounts payable   932    1,513 
Accrued expenses and other current liabilities   1,354    1,953 
Operating lease liabilities   (859)   —   
Deferred rent   —      (297)
Contract liabilities   (1,285)   (388)
Net cash used in operating activities   (33,112)   (18,339)
Cash flows from investing activities:          
Purchase of property and equipment   (1,759)   (245)
Proceeds from redemption of marketable securities   26,234    —   
Net cash provided by (used in) operating activities   24,475    (245)
Cash flows from financing activities:          
Proceeds from exercise of stock options   668    89 
Proceeds from the issuance of convertible notes   —      8,045 
Proceeds from bank loan   —      10,000 
Principal payments - bank loan   —      (667)
Payment of deferred financing costs   —      (1,287)
Payment of debt issuance costs   —      (717)
Taxes paid related to the net share settlement of equity awards   (3,400)   —   
Proceeds from issuance of common stock under the Common Stock Purchase Agreement   1,422    —   
Net cash provided by (used in) financing activities   (1,310)   15,463 
Net decrease in cash and cash equivalents and restricted cash   (9,947)   (3,121)
Cash, cash equivalents and restricted cash at beginning of period   16,333    16,497 
Cash, cash equivalents and restricted cash at end of period  $6,386   $13,376 

 

 

 

   

 

 

AEYE, INC.
Reconciliation of GAAP to Non-GAAP Financial Measures
(In thousands, except share and per share data)
(Unaudited)
            
   Three months ended June 30,  Six months ended June 30,
   2022  2021  2022  2021
GAAP net loss  $(26,467)  $(11,075)  $(51,348)  $(22,584)
Non-GAAP adjustments:                    
Stock-based compensation   6,557    2,620    11,897    4,230 
Expenses related to registration statement on Form S-1s   250    425    250    425 
Change in fair value of embedded derivative and warrant liabilities   (141)   16    (109)   119 
Stock issuance costs   28    —      28    —   
Gain on PPP Loan Forgiveness   —      (2,297)   —      (2,297)
Non-GAAP net loss  $(19,773)  $(10,311)  $(39,282)  $(20,107)
Depreciation and amortization expense   255    253    463    498 
Interest income and other   (350)   (2)   (774)   (5)
Interest expense and other   279    1,264    622    1,952 
Provision for income tax expense   18    —      26    —   
Adjusted EBITDA  $(19,571)  $(8,796)  $(38,945)  $(17,662)
                     
GAAP net loss per share attributable to common stockholders:                    
Basic and diluted  $(0.17)  $(0.11)  $(0.33)  $(0.22)
Non-GAAP net loss per share attributable to common stockholders:                    
Basic and diluted  $(0.13)  $(0.10)  $(0.25)  $(0.20)
Shares used in computing GAAP net loss per share attributable to common stockholders:                    
Basic and diluted   157,310,419    101,458,886    156,071,676    101,398,851 
Shares used in computing Non-GAAP net loss per share attributable to common stockholders:                    
Basic and diluted   157,310,419    101,458,886    156,071,676    101,398,851 

 

 

   

 

 

Contacts

 

Media:

Jennifer Deitsch

AEye, Inc.

jennifer@aeye.ai

925-400-4366

 

Andie Davis

Landis Communications Inc.

AEye@landispr.com

415-717-9133

 

Investors:

Clyde Montevirgen

AEye, Inc.

cmontevirgen@aeye.ai

925-400-4366

 

Will Stack

Lambert & Co.

AEye@lambert.com

212-971-9718